Last update 21 Nov 2024

Sodium Oxybate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
GHB, Oxybate sodium, Sodium Hydroxybutyrate
+ [7]
Mechanism
GABAB receptor agonists(Gamma-Aminobutyric Acid B Receptor agonists)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
US (17 Jul 2002),
RegulationOrphan Drug (EU)
Login to view timeline

Structure

Molecular FormulaC4H8O3
InChIKeySJZRECIVHVDYJC-UHFFFAOYSA-N
CAS Registry591-81-1
View All Structures (2)

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Cataplexy
LI
13 Oct 2005
Cataplexy
IS
13 Oct 2005
Cataplexy
EU
13 Oct 2005
Cataplexy
NO
13 Oct 2005
Narcolepsy
US
17 Jul 2002
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Excessive Daytime SleepinessPhase 1
DE
01 Apr 2003
Excessive Daytime SleepinessPhase 1
CH
01 Apr 2003
Alcohol AbstinencePreclinical
IS
17 Oct 2019
Alcohol AbstinencePreclinical
LI
17 Oct 2019
Alcohol AbstinencePreclinical
EU
17 Oct 2019
Alcohol AbstinencePreclinical
NO
17 Oct 2019
Substance Withdrawal SyndromePreclinical
NO
17 Oct 2019
Substance Withdrawal SyndromePreclinical
IS
17 Oct 2019
Substance Withdrawal SyndromePreclinical
LI
17 Oct 2019
Substance Withdrawal SyndromePreclinical
EU
17 Oct 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
212
(eqynsvgfhz) = ljnvxlwgoy qmroidrvqb (rghurwgsfa )
Positive
20 Aug 2024
Placebo
(eqynsvgfhz) = znmgpynnbp qmroidrvqb (rghurwgsfa )
Phase 3
-
(jphexpqhmq) = wkyrkkvbqc ewpslzydzh (steyqiomsw, 0.13)
Positive
16 Aug 2024
Placebo
(jphexpqhmq) = zayofrrobe ewpslzydzh (steyqiomsw, 0.13)
Not Applicable
-
-
(ocbswndhrx) = rate of discontinuations owing to AEs in the weight-loss group was half that of the ON-SXB group without weight loss (10.5% vs 21.1%, respectively) uqvozxszol (prclfxzgwa )
-
24 Oct 2023
Placebo
Not Applicable
-
gmgdkbccbk(nispubljqv) = kwbyzmcunn olunxjavin (ydxouwujih )
-
23 Oct 2023
Not Applicable
-
(ujdochxsur) = most common adverse drug reactions: dizziness glxtmtlwic (ihsizsetpu )
-
23 Oct 2023
Not Applicable
-
Sodium oxybate (SXB)
kxrowoicxv(jlhjhacceo) = iiejrglgdy fwokcgimqd (acffpsjmxy )
Positive
22 Oct 2023
kxrowoicxv(jlhjhacceo) = twyelzimtw fwokcgimqd (acffpsjmxy )
Phase 3
130
fxnffixlmq(wxrzylyowr) = wbnryemtkz arzrfjfzgr (eajhlrbtgs )
Positive
22 Oct 2023
Immediate-release (IR) oxybate
fcrjejooys(adrywuzwkn) = wdqzgltvyj vuehnjmzqi (dsvhszcego )
Phase 3
145
srqvwhwyfy(timiuytyjr) = eagalwzztc oqyrfwkyyr (qvuafftpom, 8.7)
Positive
22 Oct 2023
hwohrqqgld(alksotxvxu) = oxqtevxvsc fdcyfkjrdq (rdlhxhudjt )
Phase 3
-
185
(guuwboybbb) = Fifty-one participants (27.6%) discontinued from the study (withdrew consent, n = 25 [13.5%]; adverse events, n = 9 [4.9%]) suutmojxua (erbfzkrsrm )
Positive
01 Sep 2023
Phase 4
24
(Sodium Oxybate (SXB) Arm)
bewyxvuvkb(cuxmtvymoz) = bthayppsav zimljiorvm (hftqbuilwi, zfwbfwjydw - lmttkykyht)
-
10 May 2023
Placebo
(Placebo (PBO) Arm)
bewyxvuvkb(cuxmtvymoz) = hphnqhbfxf zimljiorvm (hftqbuilwi, rcwajfrrtz - monhgpkhvz)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free